Onbrez 150mcg Breezhaler

Onbrez 150mcg Breezhaler belongs to the class of 'bronchodilators' primarily used to treat chronic obstructive pulmonary disease (COPD). Onbrez 150mcg Breezhaler helps to relieve symptoms like wheezing and shortness of breath. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Onbrez 150mcg Breezhaler is not indicated for use in asthma (long-term data in patients with asthma are thus far lacking).

Onbrez 150mcg Breezhaler contains 'Indacaterol' a novel and long-acting beta-adrenergic receptor agonist. It relaxes the muscles in the airways and increases airflow to the lungs. Onbrez 150mcg Breezhaler makes breathing easier by widening the airways. Onbrez 150mcg Breezhaler has a rapid onset action.

Your doctor will advise on how often you take Onbrez 150mcg Breezhaler based on your medical condition. The common side effects of Onbrez 150mcg Breezhaler include nausea, dizziness, palpitations (irregular heartbeat), shakiness (tremor), runny nose, sore throat, headache, and cough. Most of these side effects of Onbrez 150mcg Breezhaler do not require medical attention and gradually resolve over time. However, if the side effects are persistent, please seek medical help. 

Try not to stop taking this medicine of your own. Brief your medical history if you have any heart, liver, kidney diseases, hyperthyroidism (overactive thyroid), seizure (fits), asthma, high blood pressure, and diabetes before taking Onbrez 150mcg Breezhaler. Please check with your doctor if you are pregnant or currently breastfeeding before taking Onbrez 150mcg Breezhaler. Avoid drinking alcohol while taking Onbrez 150mcg Breezhaler as it can worsen your dizziness. Onbrez 150mcg Breezhaler is not recommended for use in patients younger than 18 years of age.

Onbrez 150mcg Breezhaler contains 'Indacaterol' a beta-adrenergic receptor agonist and belongs to the class of 'bronchodilators'. Onbrez 150mcg Breezhaler is used to treat breathing difficulties in chronic obstructive pulmonary disease (COPD). Onbrez 150mcg Breezhaler helps to relieve coughing, wheezing, and shortness of breath. Onbrez 150mcg Breezhaler relaxes the muscles in the airways and increases airflow to the lungs. Onbrez 150mcg Breezhaler makes breathing easier by widening the airways.

Inform your doctor beforehand if you have any heart, liver, kidney diseases, hyperthyroidism (overactive thyroid), seizure (fits), high blood pressure, and diabetes before taking Onbrez 150mcg Breezhaler. Bronchodilators also cause hypokalaemia (low potassium levels in the blood) in some patients leading to severe heart diseases, so Onbrez 150mcg Breezhaler should be cautiously administered. Bronchodilators like Onbrez 150mcg Breezhaler can cause a rise in blood glucose levels. Please monitor your blood glucose levels if you have diabetes and inform your doctor so that the dose can be adjusted accordingly. Bronchodilators may also cause rapid and irregular heartbeat, blood pressure changes, and electrocardiogram (ECG) changes in heart patients. Let your doctor know if you are pregnant or a lactating mother before starting Onbrez 150mcg Breezhaler. Do not drive or operate machinery if you experience dizziness, increased/uneven heart rate, and shakiness while using Onbrez 150mcg Breezhaler. Drinking alcohol can worsen your dizziness and affect your mental ability when you are treated with Onbrez 150mcg Breezhaler; hence please avoid alcohol consumption. Onbrez 150mcg Breezhaler is not recommended in patients younger than 18 years of age.  

• Onbrez 150mcg Breezhaler is for use only in people with chronic obstructive pulmonary disease (COPD) and not to treat asthma.
• Onbrez 150mcg Breezhaler is not a rescue medicine, so it will not work fast enough to treat a bronchospasm attack. 
• Do not take capsule form by mouth and should be used only in the Neohaler device.